Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38371
CAS Number:
107753-78-6
Zafirlukast
Purity:
≥ 98 % (HPLC)
Synonym(s):
Cyclopentyl N -[3-[[2-méthoxy-4-[[[(2-méthylphényl)sulfonyl]amino]carbonyl]phényl]méthyl]-1-méthyl-1 H -indol-5-yl]carbamate, Ester cyclopentylique de l'acide N- [3-[[2-méthoxy-4-[[[(2-méthylphényl)sulfonyl]amino]carbonyl]phényl]méthyl]-1-méthyl-1 H -indol-5-yl]carbamique
Documents
$48.27 /100 mg
Taille
Request Bulk Quote
Product Information

Conserver sous gaz inerte

Synonyms
Cyclopentyl N -[3-[[2-méthoxy-4-[[[(2-méthylphényl)sulfonyl]amino]carbonyl]phényl]méthyl]-1-méthyl-1 H -indol-5-yl]carbamate, Ester cyclopentylique de l'acide N- [3-[[2-méthoxy-4-[[[(2-méthylphényl)sulfonyl]amino]carbonyl]phényl]méthyl]-1-méthyl-1 H -indol-5-yl]carbamique
CAS Number
107753-78-6
Purity
≥ 98 % (HPLC)
Molecular Formula
C31H33N3O6S
Molecular Weight
575.68
MDL Number
MFCD00864775
PubChem ID
5717
Appearance
Poudre blanche à grise à brune à cristalline
Conditions
Conserver entre 2 et 8 °C
General Information
Synonyms
Cyclopentyl N -[3-[[2-méthoxy-4-[[[(2-méthylphényl)sulfonyl]amino]carbonyl]phényl]méthyl]-1-méthyl-1 H -indol-5-yl]carbamate, Ester cyclopentylique de l'acide N- [3-[[2-méthoxy-4-[[[(2-méthylphényl)sulfonyl]amino]carbonyl]phényl]méthyl]-1-méthyl-1 H -indol-5-yl]carbamique
CAS Number
107753-78-6
Purity
≥ 98 % (HPLC)
Molecular Formula
C31H33N3O6S
Molecular Weight
575.68
MDL Number
MFCD00864775
PubChem ID
5717
Appearance
Poudre blanche à grise à brune à cristalline
Conditions
Conserver entre 2 et 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

Zafirlukast is widely utilized in research focused on:

  • Asthma Management: This compound is primarily used as a leukotriene receptor antagonist, helping to reduce inflammation and bronchoconstriction in asthma patients, thereby improving their breathing and overall quality of life.
  • Allergy Treatment: It is effective in managing allergic rhinitis symptoms, providing relief from nasal congestion and other allergy-related issues, making it a valuable option for individuals suffering from seasonal allergies.
  • Clinical Research: Zafirlukast is often studied in clinical trials to evaluate its efficacy in combination therapies for respiratory diseases, offering insights into new treatment protocols and improving patient outcomes.
  • Pharmaceutical Development: The compound serves as a model for developing new drugs targeting similar pathways, aiding researchers in creating more effective treatments for chronic respiratory conditions.
  • Personalized Medicine: Its application in pharmacogenomics allows for tailored treatment plans based on individual patient responses, enhancing therapeutic effectiveness and minimizing side effects.

Citations